Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Iskar

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nature Structural & Molecular Biology|June 29, 2023
Readout of histone methylation by Trim24 locally restricts chromatin opening by p53Luke Isbel, Murat Iskar, Sevi Durdu, et al.
Nature Genetics|February 7, 2020
The landscape of viral associations in human cancersMarc Zapatka, Ivan Borozan, Daniel S Brewer, et al.
Molecular Systems Biology|March 21, 2013
Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machinesAlessandro Ori, Niccolò Banterle, Murat Iskar, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Molecular Systems Biology|May 24, 2019
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networksJan-Philipp Mallm, Murat Iskar, Naveed Ishaque, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Cancer Letters|September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastomaObada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.
Nature Communications|January 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature Structural & Molecular Biology|June 29, 2023
Readout of histone methylation by Trim24 locally restricts chromatin opening by p53Luke Isbel, Murat Iskar, Sevi Durdu, et al.
Nature Genetics|February 7, 2020
The landscape of viral associations in human cancersMarc Zapatka, Ivan Borozan, Daniel S Brewer, et al.
Molecular Systems Biology|March 21, 2013
Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machinesAlessandro Ori, Niccolò Banterle, Murat Iskar, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Molecular Systems Biology|May 24, 2019
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networksJan-Philipp Mallm, Murat Iskar, Naveed Ishaque, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Cancer Letters|September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastomaObada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.
Nature Communications|January 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Pageof 4